Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,066,843    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $65,005,693      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,940 Incyte Corp $895,340 Immunome Inc. $143,648 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,940 Incyte Corp $895,340 Immunome Inc. $143,648
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 21 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-05-15 4 S $39.10 $195,546 D/D (5,000) 3,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-05-12 4 S $39.15 $195,791 D/D (5,000) 3,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-14 4 OE $17.86 $196,460 D/D 11,000 334,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-04-27 4 OE $9.86 $197,200 D/D 20,000 134,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-01 4 OE $9.86 $197,200 D/D 20,000 133,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-07 4 AS $65.87 $197,613 I/I (3,000) 13,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-10-10 4 AS $66.76 $200,291 I/I (3,000) 45,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-08-12 4 AS $134.72 $202,083 I/I (1,500) 28,758 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-07-07 4 S $139.07 $208,600 I/I (1,500) 30,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-08-17 4 S $21.00 $210,000 D/D (10,000) 6,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-17 4 OE $26.49 $211,920 D/D 8,000 303,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-11 4 OE $6.46 $212,500 D/D 25,000 194,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-11-22 4 OE $21.51 $215,100 D/D 10,000 337,080 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-02-03 4 OE $21.51 $215,100 D/D 10,000 338,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-09 4 OE $21.51 $215,100 D/D 10,000 306,443 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-09 4 OE $21.51 $215,100 D/D 10,000 308,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-02-20 4 AS $16.96 $220,481 D/D (13,000) 20,642 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-27 4 OE $26.49 $220,741 D/D 8,333 303,885 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-28 4 OE $26.49 $220,741 D/D 8,333 303,885 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-29 4 OE $26.49 $220,768 D/D 8,334 303,886 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-23 4 AS $55.22 $220,880 D/D (4,000) 153,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-15 4 OE $37.46 $224,760 D/D 6,000 309,689 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-16 4 OE $37.46 $224,760 D/D 6,000 309,689 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-10 4 OE $26.49 $225,509 D/D 8,513 312,352 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-09-19 4 AS $23.00 $230,000 D/D (10,000) 6,695 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21  22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 21 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us